GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apex Biotechnology Corp (TPE:1733) » Definitions » Additional Paid-In Capital

Apex Biotechnology (TPE:1733) Additional Paid-In Capital : NT$68 Mil(As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Apex Biotechnology Additional Paid-In Capital?


Apex Biotechnology's quarterly additional paid-in capital stayed the same from Jun. 2024 (NT$68 Mil) to Sep. 2024 (NT$68 Mil) and stayed the same from Sep. 2024 (NT$68 Mil) to Dec. 2024 (NT$68 Mil).

Apex Biotechnology's annual additional paid-in capital stayed the same from Dec. 2022 (NT$68 Mil) to Dec. 2023 (NT$68 Mil) and stayed the same from Dec. 2023 (NT$68 Mil) to Dec. 2024 (NT$68 Mil).

Apex Biotechnology Additional Paid-In Capital Historical Data

The historical data trend for Apex Biotechnology's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apex Biotechnology Additional Paid-In Capital Chart

Apex Biotechnology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 66.78 68.37 68.37 68.37 68.37

Apex Biotechnology Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.37 68.37 68.37 68.37 68.37

Apex Biotechnology Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Apex Biotechnology Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Apex Biotechnology's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Apex Biotechnology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apex Biotechnology Corp (TPE:1733) » Definitions » Additional Paid-In Capital
Comparable Companies
ROCO:6864 ROCO:6634 ROCO:6926 ROCO:6733 ROCO:4911 ROCO:4169 TPE:6885 ROCO:8279 ROCO:7808 ROCO:6986 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No.7, Li-Hsin 5th Road, Hsinchu Science Park, Hsinchu, TWN, 30078
Website
https://www.apexbio.com
Apex Biotechnology Corp engages mainly in the research, development, production, manufacturing, and selling of biochemical testing instruments and detection strips, and the trade of products and components relevant to the core business. Its products offer Diabetes Care, Home Diagnostics, and Point-of-Care Clinical and Laboratory. Its product offerings include Eclipse plus multipurpose analyzer, Glucosure HT blood glucose monitoring system, and HemoSmart GOLD hemoglobin screening system among others. Company operates in Taiwan, USA, Italy, Austria, China , Others. Majority of revenue is from USA.

Apex Biotechnology Headlines

No Headlines